review

    Cards (72)

    • Parasympathetic Nervous System
      • Preganglionic neurons from the cranial and sacral regions of the spinal cord synapse with the postganglionic neurons on an outside ganglia
      • Parasympathetic innervation results in pupil constriction, salivation, airway constriction, bradycardia, stomach digestion, intestinal digestion, bladder constriction, and reproductive system blood flow increase
      • This system typically innervates cardiac smooth muscle, gland cells, and nerve terminals
    • Cranial nerves involved in parasympathetic innervation
      • Oculomotor (3)
      • Facial (7)
      • Glossopharyngeal (9)
      • Vagus (10)
    • Sacral nerves involved in parasympathetic innervation
      • 2
      • 3
      • 4
    • NN receptors
      Located in the CNS, postganglionic cell body, and dendrites. Their structure is a pentamer with only ɑ and β subunits. They work through Na+ and K+ depolarization ion channels
    • NM receptors
      Located in the skeletal neuromuscular junction. Their structure is that of a pentamer with ɑ, β, γ, and δ subunits. They work through Na+ and K+ depolarization ion channels
    • M1 receptors
      Located in the nerves. Their structure is a Gq/11 protein coupled receptor. They work through the IP3 and DAG cascade. Has a stimulatory effect. Innervation causes the brain to increase cognition and memory while the stomach is told to increase pepsinogen and HCl release
    • M2 receptors
      Located in the heart, nerves, and smooth muscle. Their structure is a Gi/o protein coupled receptor. They work through cAMP inhibition and activation of K+ channels. Has an inhibitory effect. Causes the SA node to decrease chronotropy, atria to decrease inotropy, AV node to decrease dromotropy/increase refractory period, and the ventricles to decrease inotropy
    • M3 receptors
      Located in the glands, smooth muscles, and endothelial cells. Their structure is a Gq/11 protein coupled receptor. They work through the IP3 and DAG cascade. Has a stimulatory effect. Causes increased tears, saliva, bronchial secretions and constriction, digestive enzymes, GI mucus and peristalsis, iris miosis and lens, and increases detrusor contraction/trigone and sphincter relaxation
    • M4 receptors
      Located in the CNS. Their structure is a Gi/o protein coupled receptor. They work through cAMP inhibition and activation of K+ channels
    • M5 receptors
      Located in the CNS. Their structure is a Gq/11 protein coupled receptor. They work through the IP3 and DAG cascade
    • Cholinomimetics
      • Direct Acting: Muscarinic and nicotinic receptor agonists
      • Indirect Acting: Cholinesterase inhibitors
    • Nicotine
      • Works on the ɑ4, ɑ7 and β2 subunits of nicotinic receptors
      • In the brain, it causes dopaminergic receptors to release dopamine causes euphoria, but also dependence
      • Drug is slowly absorbed transdermally and mucosal dosage forms
    • Varenicline
      • Partial nicotinic acetylcholine receptor agonist producing a modest dopamine release while blocking real nicotine from binding
      • This drug is well tolerated, but can lead to some nausea, vomiting, abnormal dreams, depression, headache, insomnia, and irritability
      • This drug is mainly excreted in the urine unchanged
    • Cholinergic Toxidrome
      • S - Salivation
      • L - Lacrimation
      • U - Urination
      • D - Diaphoresis
      • G - GI Upset
      • E - Emesis
      • M - Miosis
      • B - Bradycardia
    • Bethanechol
      • Direct M3 agonist that stimulates bladder contraction
      • This drug is a quaternary amine, meaning it cannot cross the blood brain barrier
      • This drug can also cause abdominal pain, colicky pain, nausea, diarrhea, and borborygmi
    • Carbachol
      • Directly stimulates M1 and M2 to decrease intraocular pressure and constrict the iris
      • May cause blurred vision and ocular irritation
    • Methacholine
      • Works by directly acting on M2 and M3 receptor to cause smooth muscle contraction in the airways and increased bronchial secretions during stress tests
      • Used to diagnosis respiratory diseases, not used as their treatment
      • May cause bronchoconstriction when given, but has a short duration of action of ~30 minutes
    • Cevimeline
      • Direct agonist of M1 and M3 that results in increased saliva, sweat, and smooth muscle contractions in the glands
      • Adverse effects include diarrhea and hyperhidrosis
    • Pilocarpine
      • Directly agonizes M1, M2, and M3 receptors leading to ciliary muscle contraction in open-angle glaucoma, opening of the angle in closed-angle glaucoma, and increasing salivary to treat xerostomia
      • Adverse effects are only hyperhidrosis since they're less likely to occur with eye drops
    • Myasthenia Gravis
      • Autoimmune disease that attacks nicotinic receptors in the skeletal neuromuscular junction. This can happen by receptor cross-linking, lysis of the postsynaptic membrane, and/or binding directly to the receptors and inhibiting their function
      • Symptoms: Ptosis, diplopia, muscle weakness, and trouble speaking
      • This disease is treated by AChE inhibitors which increase ACh in the synaptic cleft
    • Neostigmine
      • Reversible AChE inhibitor
      • This drug does not cross the blood brain barrier
      • Used to treat myasthenia gravis but has SLUDGE MB side effects
    • Physostigmine
      • Reversible AChE inhibitor
      • This drug does cross the blood brain barrier
      • Used to treat anticholinergic poisoning
    • Pyridostigmine
      • Reversible AChE inhibitor
      • Used to treat myasthenia gravis and neuromuscular blockade with SLUDGE MB side effects
    • Alzheimer's Disease
      • Characterized by the impaired release of ACh and deficits in the expression of nicotinic and muscarinic receptors
      • AChE inhibitors are typically used to treat this disease by prolonging the half-life of ACh in the synaptic cleft
    • Donepezil
      • Reversible AChE inhibitor
      • This drug does cross the blood brain barrier
      • Used to treat Alzheimer's disease with SLUDGE MB side effects
    • Galantamine
      • Reversible AChE inhibitor and also a positive allosteric modulator of neuronal nicotinic ACh receptors
      • This drug does cross the blood brain barrier
      • Used to treat Alzheimer's disease with dermatological and SLUDGE MB side effects
    • Rivastigmine
      • Reversible AChE inhibitor
      • Used to treat Alzheimer's disease and Parkinson's disease
      • Adverse drug reactions are SLUDGE MB
    • Anticholinergic Toxidrome
      • Flushed skin 'red as a beat'
      • Xerostomia 'dry as a bone'
      • Mydriasis 'blind as a bat'
      • Confusion ' mad as a hatter'
      • Hyperthermia ' hot as a desert'
      • Urinary retention 'full as a flask'
    • Anticholinergic drugs have a high risk of cognitive impairment and tend to lead to dementia if used for long-term
    • Scopolamine
      • Competitive antagonist at muscarinic receptor
      • This drug does cross the blood brain barrier
      • Used to reduce vertigo and nausea
      • Adverse drug reactions are tachycardia, blurred vision, xerostomia, and delirium
    • Dicyclomine
      • Competitive antagonist at the M1 and M4 receptors that reduces smooth muscle and secretory activity of the gut
      • Likely well absorbed into the body unlike other anticholinergic drugs
      • Used for IBS and minor diarrhea
      • Adverse drug reactions are tachycardia, confusion, urinary retention, and increase intraocular pressure
    • Atropine
      • Competitive muscarinic receptor antagonist that relaxes the iris sphincter and ciliary body
      • Has a high duration of action , up to 2 weeks
      • Used for secretions that happen towards the end of the life
      • Anti-SLUDGE MB adverse reactions might happen
    • Ipratropium
      • Competitive muscarinic receptor antagonist of the M3 receptor to reduce bronchospasm
      • This drug is quaternary amine so it does not cross the blood brain barrier
      • Used for rhinorrhea and asthma and mainly causes xerostomia and cough
    • Oxybutynin
      • Muscarinic antagonist that reduces detrusor muscle tone and spasms
      • Used for incontinence and postoperative spasms
      • This medication does cross the blood brain barrier to a high degree
    • Atropine
      Eye drops that are a competitive muscarinic receptor antagonist that relaxes the iris sphincter and ciliary body
    • Atropine
      • Has a high duration of action, up to 2 weeks
      • Used for secretions that happen towards the end of life
    • Atropine adverse reactions may include anti-SLUDGE MB
    • Ipratropium (Atrovent)
      Competitive muscarinic receptor antagonist of the M3 receptor to reduce bronchospasm
    • Ipratropium is a quaternary amine so it does not cross the blood brain barrier
    • Ipratropium
      Used for rhinorrhea and asthma, mainly causes xerostomia and cough
    See similar decks